International Journal of Clinical Pharmacy

, Volume 35, Issue 3, pp 323–326 | Cite as

Level and factors of benzodiazepines misuse in Albania

  • Suela KelliciEmail author
  • Ela Hoti
  • Genc Burazeri
Short Research Report


Background There is little evidence on benzodiazepine misuse and associated factorsin transitional countries of the Western Balkans. Objective The aim of this study was to assess the level and socioeconomic correlates of misuse of benzodiazepine drugs in the Albanian adult population. Method We conducted a cross-sectional study including a representative sample of 422 individuals (158 men and 264 women) who were benzodiazepines users. A structured questionnaire included data on age, gender, type of drug used, and awareness of possibility to develop dependence and continuation of therapy after prescription. Results 289 individuals reported treatment continuation compared with 89 participants who reported no continuation of benzodiazepine drugs. There were no significant age group (P = 0.351), sex (P = 0.454), or educational differences (P = 0.117) in treatment continuation. Age was inversely related to the awareness of becoming dependent with the prolonged use of benzodiazepines (78.4 % of the persons aged ≤40 years were aware of the dependence versus 51.9 % in the age group >40 years; P = 0.002). Conclusion Our study provides pioneering evidence on the use and misuse of benzodiazepines in Albania. Findings from this study may influence the reforms and policy formulation related to drug misuse in Albania.


Albania Awareness Benzodiazepine Medicine information Misuse 




Conflicts of interest



  1. 1.
    Petitjean S, Ladewig D, Meier CR, Amrein R, Wiesbeck GA. Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. Int Clin Psychopharmacol. 2007;22:292–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Joint Formulary Committee. British National Formulary 60. UK: BMJ Publishing Group and Royal Pharmaceutical Society of Great Britain; 2010.Google Scholar
  3. 3.
    National Institute for Health and Clinical Excellence. Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalized anxiety disorder) in adults in primary, secondary and community care. Clinic Guid. 2011; 113.Google Scholar
  4. 4.
    Ashton H. The diagnosis and management of benzodiazepine withdrawal. Curr Opin Psychiatry. 2005;18:249–55.PubMedCrossRefGoogle Scholar
  5. 5.
    Williams H, Oyeffeso A, Ghodse AH. Benzodiazepine misuse and dependence among opiate addicts in treatment. Irish J Psychol Med. 1996;13:62–4.Google Scholar
  6. 6.
    Levine DA. ‘Pharming’: the abuse of prescription and over-the-counter drugs in teens. Curr Opin Pediatr. 2007;19:270–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Magrini N, Vaccheri A, Parma E, D’Alessandro R, Bottoni A, Occhionero M, Montanaro N. Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol. 1996;50:19–25.PubMedCrossRefGoogle Scholar
  8. 8.
    Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol. 1998;51:273–83.PubMedCrossRefGoogle Scholar
  9. 9.
    Curran HV, Collins R, Fletcher S, Kee SCY, Woods B, Iliffe S. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med. 2003;33:1223–37.PubMedCrossRefGoogle Scholar
  10. 10.
    Heather N, Bowie A, Ashton H, McAvoy B, Spencer I, Brodie J, Giddings D. Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addict Res Theory. 2004;12:141–54.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.Pharmaceutical Department, Faculty of MedicineUniversity of TiranaTiranaAlbania
  2. 2.Department of International Health, School for Public Health and Primary Care (CAPHRI), Faculty of Health, Medicine and Life SciencesMaastricht UniversityMaastrichtThe Netherlands

Personalised recommendations